AU2003218969A1 - Modulation of t lymphocytes using dp iv inhibitors - Google Patents

Modulation of t lymphocytes using dp iv inhibitors

Info

Publication number
AU2003218969A1
AU2003218969A1 AU2003218969A AU2003218969A AU2003218969A1 AU 2003218969 A1 AU2003218969 A1 AU 2003218969A1 AU 2003218969 A AU2003218969 A AU 2003218969A AU 2003218969 A AU2003218969 A AU 2003218969A AU 2003218969 A1 AU2003218969 A1 AU 2003218969A1
Authority
AU
Australia
Prior art keywords
lymphocytes
inhibitors
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003218969A
Other versions
AU2003218969A8 (en
Inventor
Hans-Ulrich Demuth
Martin Hildebrandt
Torsten Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vivoryon Therapeutics AG
Original Assignee
Probiodrug AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiodrug AG filed Critical Probiodrug AG
Publication of AU2003218969A1 publication Critical patent/AU2003218969A1/en
Publication of AU2003218969A8 publication Critical patent/AU2003218969A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
AU2003218969A 2002-02-01 2003-02-03 Modulation of t lymphocytes using dp iv inhibitors Abandoned AU2003218969A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31910802P 2002-02-01 2002-02-01
US60/319,108 2002-02-01
PCT/EP2003/001044 WO2003063903A2 (en) 2002-02-01 2003-02-03 Modulation of t lymphocytes using dp iv inhibitors

Publications (2)

Publication Number Publication Date
AU2003218969A1 true AU2003218969A1 (en) 2003-09-02
AU2003218969A8 AU2003218969A8 (en) 2008-02-07

Family

ID=27662897

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003218969A Abandoned AU2003218969A1 (en) 2002-02-01 2003-02-03 Modulation of t lymphocytes using dp iv inhibitors

Country Status (2)

Country Link
AU (1) AU2003218969A1 (en)
WO (1) WO2003063903A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242566A1 (en) 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
WO2005016911A1 (en) 2003-08-13 2005-02-24 Takeda Pharmaceutical Company Limited 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
JP2007505121A (en) 2003-09-08 2007-03-08 武田薬品工業株式会社 Dipeptidyl peptidase inhibitor
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CN102127053A (en) 2004-03-15 2011-07-20 武田药品工业株式会社 Dipeptidyl peptidase inhibitors
EP1753730A1 (en) 2004-06-04 2007-02-21 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
EP2805953B1 (en) 2004-12-21 2016-03-09 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
PL1942898T5 (en) 2005-09-14 2014-10-31 Takeda Pharmaceuticals Co Dipeptidyl peptidase inhibitors for treating diabetes
CA2622642C (en) 2005-09-16 2013-12-31 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9206628A (en) * 1991-11-22 1993-05-01 Boehringer Ingelheim Pharma PROLINABORONATE ESTER AND METHOD FOR ITS PREPARATION.
US6534626B1 (en) * 1997-12-01 2003-03-18 The United States Of America As Represented By The Department Of Health & Human Services Chemokine variants

Also Published As

Publication number Publication date
WO2003063903A3 (en) 2007-12-21
WO2003063903A2 (en) 2003-08-07
AU2003218969A8 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
AU2003300832A1 (en) NF-KappaB INHIBITORS
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003261434A1 (en) Iminothiazolidinones as inhibitors of hcv replication
AU2003303483A1 (en) Ccr8 inhibitors
WO2003063797A8 (en) Cycloalkyl inhibitors of potassium channel function
AU2003223188A1 (en) Adhesives
AU2003218969A1 (en) Modulation of t lymphocytes using dp iv inhibitors
AU2003299883A1 (en) Ccr8 inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
AU2003244750A1 (en) Polymerisation inhibitor
AU2003288705A1 (en) Modulators (inhibitors/activators) of histone acetyltransferases
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003216322A1 (en) Inhibitors of tubulin polymerization
AU2003295427A1 (en) Flaviviris fusion inhibitors
AU2003299901A1 (en) Thrombin inhibitors
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003234925A1 (en) TGF-Alpha EXPRESSION INHIBITORS
AU2003224941A1 (en) NF-KappaB INHIBITORS
AU2003252593A1 (en) Sulfotransferase inhibitors
AU2003295638A1 (en) NOVEL INHIBITORS OF Beta-LACTAMASE
AU2003292720A1 (en) Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same
AU2003290417A1 (en) Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use
AU2002316552A1 (en) Inhibitor of t cell activation
AU2003295790A1 (en) Modulation of iap-like expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase